| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 48,870 | 47,802 | 45,028 | | Cost of Revenue | 25,534 | 23,064 | 15,323 | | | Gross Profit | 23,336 | 24,738 | 29,705 | | | Operating Expenses | | Research Development | 8,896 | 9,441 | 9,247 | | Selling General and Administrative | 35,311 | 39,706 | 33,499 | | Non Recurring |
-
|
-
|
-
| | Others | 202 | 2,815 | 1,090 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (21,073) | (27,224) | (14,131) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,506 | 6,526 | 6,383 | | Earnings Before Interest And Taxes | (18,567) | (20,698) | (7,748) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (18,567) | (20,698) | (7,748) | | Income Tax Expense | 539 | 671 | 487 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (19,106) | (21,369) | (8,235) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (19,106) | (21,369) | (8,235) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($19,106) | ($21,369) | ($8,235) |
|
0.29% Nasdaq 
Income Statement
